# ClinicalTrials.gov record NCT01155206

> PeptideScanner retained ClinicalTrials.gov record NCT01155206 at 2026-07-30T21:39:57.683Z. Its registry update date was 2015-12-02, and PeptideScanner's reviewed identity mapping was glucagon.

- Evidence object: `story:clinicaltrials-gov-nct01155206-glucagon:v1`
- Evidence domain: Clinical trials
- Date in source: 2015-12-02
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct01155206-glucagon/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct01155206-glucagon-v1.json
- Content SHA-256: `d3116536aed858bfae0f82b282beb1bebe769bec892baebf04630d0e85b0e335`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT01155206 ([`ctg-observation-nct01155206-2015-12-02-534337500260`](#source-ctg-observation-nct01155206-2015-12-02-534337500260))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT01155206 at 2026-07-30T21:39:57.683Z. Its registry update date was 2015-12-02, and PeptideScanner's reviewed identity mapping was glucagon. ([`ctg-observation-nct01155206-2015-12-02-534337500260`](#source-ctg-observation-nct01155206-2015-12-02-534337500260))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT01155206 at 2026-07-30T21:39:57.683Z. Its registry update date was 2015-12-02, and PeptideScanner's reviewed identity mapping was glucagon. ([`ctg-observation-nct01155206-2015-12-02-534337500260`](#source-ctg-observation-nct01155206-2015-12-02-534337500260))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct01155206-2015-12-02-534337500260`](#source-ctg-observation-nct01155206-2015-12-02-534337500260))

## Sources

<a id="source-ctg-observation-nct01155206-2015-12-02-534337500260"></a>
- **ClinicalTrials.gov record NCT01155206 · retained source version 2015-12-02:5343375002602a282ae81688c00dc0f3b4a371bc7e63363f76708a656e513956** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT01155206) (`ctg-observation-nct01155206-2015-12-02-534337500260`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT01155206." Version 1, published 2026-08-09. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct01155206-glucagon-v1.json SHA-256: d3116536aed858bfae0f82b282beb1bebe769bec892baebf04630d0e85b0e335.